Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial (Q81492586)
Jump to navigation
Jump to search
scientific article published on 16 November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial |
scientific article published on 16 November 2005 |
Statements
Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial (English)
Anna Potamianou
Nikolaos Androulakis
Pavlos Papakotoulas
Helen Toufexi
Christos Latoufis
Charalambos Kouroussis
Charalambos Christofilakis
Nikolaos Xenidis
Vassilios Georgoulias
Aristidis Polyzos
16 November 2005